Particle counting laboratory according to the AAMI TIR42 standard

Medical device professionals, you want to analyze them according to the AAMI TIR42?

What is AAMI ?

First, AAMI develops standards for counting particulate contamination in Medical Devices. 

The AAMI Technical Information Report (TIR) addresses vascular exposure to particulate matter resulting from the manufacturing environment and use of medical devices.

This TIR has several objectives to assist manufacturers of vascular medical devices, as follows: 

  • Determine the source of the particulate matter,
  • establish product particle limits,
  • define appropriate test methods, and
  • assess the clinical relevance of particulate contamination.

COFRAC ISO 17025 accredited, how does FILAB support you in particle counting analysis according to AAMI TIR42?

FILAB is able to assist you in the analysis of particle counts according to AAMI TIR42. Indeed, the laboratory offers to industrialists specialized in the manufacture of medical devices technical skills and a state-of-the-art analytical park.

The aim of this equipment is to respond in the best possible way and in a reactive manner to their request and to offer them the most appropriate services and a tailor-made follow-up. It is also possible to perform these analysis on an emergency basis.  

In order to respond accurately and reliably to these issues, FILAB offers tailor-made support for particle identification in your DMs according to AAMI TIR42 but also USP788, PE 2.9.19, and ISO 19227…

  • Particle extraction and counting on implants – AAMI TIR42 methodology
  • Particle counting on implantable DM by Optical Microscope
  • Particle contamination analysis 
  • Identification of particles in your pharmaceutical solutions by Scanning Electron Microscopy (SEM)
  • Analysis of your pharmaceutical solutions by infrared microscopy (FTIR)
  • Analysis and identification of particles in your pharmaceutical solutions by ICP-MS, ICP-AES

For more information, consult our expert’s word or contact us : – tel : or ask for a quote here.

AAMI TIR42 is a guidance document that provides recommendations on how to test medical device materials for chemicals that may pose a risk to patient safety. To identify and quantify these chemicals, AAMI TIR42 recommends using several different analysis methods.


  1. One of the recommended analysis methods is gas chromatography-mass spectrometry (GC-MS), which is used to separate and identify small molecules in complex mixtures. This technique involves looking at the individual components of a mixture and analyzing their physical properties to determine what they are.


  1. Another method is high-performance liquid chromatography (HPLC), which is used to separate and identify organic molecules in complex mixtures. This technique is particularly useful for identifying chemicals that may be present in very small amounts.


  1. A third recommended analysis method is Fourier transform infrared spectroscopy (FTIR), which is used to identify the chemical functional groups present in a material. FTIR works by analyzing the wavelengths of light that are absorbed by a sample, which can reveal the different chemical bonds present.


  1. X-ray photoelectron spectroscopy (XPS) is another recommended analysis method. This technique is used to identify and quantify the elements present in a sample. It works by irradiating the sample with X-rays and measuring the energy of the electrons that are emitted.


  1. Finally, inductively coupled plasma optical emission spectroscopy (ICP-OES) is recommended for determining the elemental composition of a sample. This technique involves ionizing the sample and measuring the wavelengths of light emitted by the excited atoms.


AAMI TIR42 recommends several different analysis methods for identifying and quantifying chemicals in medical device materials, including GC-MS, HPLC, FTIR, XPS, and ICP-OES. These techniques help to ensure that medical devices are safe for patient use by identifying any potentially harmful chemicals that may be present

Particle contamination counting is an important aspect of testing for medical device materials, as it can help to ensure their safety and effectiveness. AAMI TIR42 provides guidelines on how to perform particle contamination counting to detect any microscopic particles that may be present in the material.


Particles can come from various sources, including the manufacturing process, the environment, or the materials themselves. They can be foreign bodies in the material, or they can be generated by the wear and tear of the device as it is used. Particle contamination can lead to a host of problems, including inflammation, thrombosis, and other adverse reactions, making it important to detect and measure the degree of contamination.


AAMI TIR42 recommends performing particle contamination counting using optical microscopy, which involves examining a sample of the material under a microscope to count and categorize the particles present. The size, shape, and composition of the particles can also be assessed to determine their potential impact on the device's safety and effectiveness.


By performing particle contamination counting according to AAMI TIR42 standards, medical device manufacturers can identify and quantify any particle contamination present in their materials and take appropriate action to ensure the safety and efficacy of their devices. This is especially important for medical devices that will be implanted or used in close contact with the body, as particle contamination can have serious consequences for patient health.


Externalizing your particle contamination counting can be beneficial for several reasons, particularly in ensuring that you are obtaining accurate and unbiased results. AAMI TIR42 recommends that particle contamination counting should be performed by an external testing laboratory that specializes in this type of analysis.

  • Externalizing particle contamination counting allows for an objective evaluation of the materials. An external laboratory has no vested interest in the outcome of the analysis, which can help to ensure that the results are impartial and accurate. Additionally, external laboratories may have access to specialized equipment or techniques that are not available in-house, providing a more comprehensive and detailed analysis.
  • It ensures compliance with regulatory requirements. External laboratories are often accredited by regulatory bodies and must adhere to strict quality control measures, ensuring that their analysis meet the highest standards. By outsourcing particle contamination counting to an accredited laboratory, medical device manufacturers can demonstrate to regulatory agencies that they are following best practices and complying with relevant standards, such as AAMI TIR42.
  • Finally, externalizing particle contamination counting can save time and resources. Performing this type of analysis in-house requires investing in specialized equipment, training personnel, and dedicating valuable lab space. By outsourcing to an external laboratory, medical device manufacturers can free up resources to focus on other areas of product development and ensure timely and accurate results.
Anaïs DECAUX Customer Support Manager
Ask for your quote
+33 (0)3 80 52 32 05 Request
a quote